232 results on '"Rocchini, Lorenzo"'
Search Results
2. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique
3. Sexual and ejaculatory function after holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate: a single-center experience
4. Cost analysis between mini-percutaneous nephrolithotomy with and without vacuum-assisted access sheath
5. Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer
6. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy
7. Is Erectile Dysfunction a Reliable Proxy of General Male Health Status? The Case for the International Index of Erectile Function—Erectile Function Domain
8. Development of a Novel Clinical and Radiologic Risk Score to Predict Septic Complications After Urinary Decompression in Patients with Obstructive Uropathy
9. Clinical Reliability of the 2004 WHO Histological Classification System Compared With the 1973 WHO System for Ta Primary Bladder Tumors
10. Postoperative Orgasmic Function Increases over Time in Patients Undergoing Nerve-Sparing Radical Prostatectomy
11. Cost analysis between mini-percutaneous nephrolithotomy with and without vacuum-assisted access sheath
12. ORIGINAL RESEARCH—EJACULATORY DISORDERS: Acceptance of and Discontinuation Rate from Paroxetine Treatment in Patients with Lifelong Premature Ejaculation
13. MP26-19 A PROSPECTIVE STUDY ON THE INFLUENCE ON RECURRENCE OF QUITTING CIGARETTE SMOKING AT DIAGNOSIS OF PRIMARY NON MUSCLE INVASIVE BLADDER CANCER
14. MP26-18 MULTI-ISTITUTIONAL CONTROLLED STUDIES DO NO REFLECT THE PATIENTʼS COMPLIANCE TO BCG ENCOUNTERED IN CLINICAL PRACTICE. RESULTS ON 411 PATIENTS
15. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
16. ORIGINAL RESEARCH—EJACULATORY DISORDERS: Quantitative Sensory Testing of Peripheral Thresholds in Patients with Lifelong Premature Ejaculation: A Case-Controlled Study
17. Is Sperm Banking of Interest to Patients With Nongerm Cell Urological Cancer Before Potentially Fertility Damaging Treatments?
18. Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?
19. Does Educational Status Affect a Patient's Behavior Toward Erectile Dysfunction?
20. PROGRESSION OF T1 HIGH RISK INTO MUSCLE-INVASIVE BLADDER CANCER IS AN INDEPENDENT PROGNOSTIC FACTOR OF MORTALITY AFTER RADICAL CYSTECTOMY: MP61-08
21. THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT IMPACT ON CANCER SPECIFIC SURVIVAL FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER: MP61-01
22. THE NUMBER OF TRANSURETHRAL RESECTIONS IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MUSCLE- INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: MP60-18
23. IMPACT OF PRE-OPERATIVE HEMOGLOBIN VALUES AND PERI-OPERATIVE BLOOD TRANSFUSION ON CANCER SPECIFIC AND OVERALL MORTALITY AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: RESULTS FROM A SINGLE INSTITUTION COHORT: MP60-04
24. HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION: PD15-12
25. Corrigendum re 'Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study' (European Urology (2012) 62(5) (797–802), (S0302283812006082) (10.1016/j.eururo.2012.05.032))
26. Overview of the italian experience in surgical management of bladder cancer during first month of COVID-19 pandemic
27. A case of acute bleeding from a small, asymptomatic renal angiomyolipoma (AML) during pneumoperitoneum induction for a rectal tumor resulting in acute hematuria and anemia
28. Sexual and ejaculatory function after holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate: a single-center experience
29. Re: Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis
30. Surgical Management of Bladder Cancer During First Month of COVID-19 Outbreak: Lessons Learned Across Italy
31. IF A PRO-ERECTILE PHARMACOLOGICAL APPROACH IS CONSIDERED AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY, THIS SHOULD BE INITIATED SOON AFTER SURGERY: 1491
32. Acceptance of and Discontinuation Rate from Paroxetine Treatment in Patients with Lifelong Premature Ejaculation
33. Quantitative Sensory Testing of Peripheral Thresholds in Patients with Lifelong Premature Ejaculation: A Case-Controlled Study
34. PREDICTORS OF FERTILITY IN PATIENTS TREATED FOR GERMCELL TESTICULAR CANCER: 2173
35. POST-OPERATIVE ORGASMIC FUNCTION INCREASES OVER TIME IN PATIENTS SUBMITTED TO BILATERAL NERVE SPARING OPEN RADICAL PROSTATECTOMY: 921
36. IS SPERM CRYOPRESERVATION BEFORE SURGICAL TREATMENT OF INTEREST IN UROLOGIC CANCER PATIENTS?: 1743
37. TIME TO CONTINENCE RECOVERY IS AN INDEPENDENT PREDICTOR OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: 1183
38. MP38-15 SYSTEMATIC URETERAL FROZEN SECTIONS AT RADICAL CYSTECTOMY. HOW MUCH IS IT REALLY USEFUL?
39. Corrigendum re “Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study” [Eur Urol 2012;62:797–802]
40. Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer
41. The Clinical Value of PSA Increase during Intravesical Adjuvant Therapy for Nonmuscle-Invasive Bladder Cancer
42. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy
43. MP26-19 A PROSPECTIVE STUDY ON THE INFLUENCE ON RECURRENCE OF QUITTING CIGARETTE SMOKING AT DIAGNOSIS OF PRIMARY NON MUSCLE INVASIVE BLADDER CANCER
44. Assessing the impact on morbidity and mortality of neoadjuvant chemotherapy in patients with high-risk and muscle invasive bladder cancer eligible for radical cystectomy.
45. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
46. MP60-18 THE NUMBER OF TRANSURETHRAL RESECTIONS IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MUSCLE- INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY
47. MP61-08 PROGRESSION OF T1 HIGH RISK INTO MUSCLE-INVASIVE BLADDER CANCER IS AN INDEPENDENT PROGNOSTIC FACTOR OF MORTALITY AFTER RADICAL CYSTECTOMY
48. MP61-01 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT IMPACT ON CANCER SPECIFIC SURVIVAL FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER
49. MP60-04 IMPACT OF PRE-OPERATIVE HEMOGLOBIN VALUES AND PERI-OPERATIVE BLOOD TRANSFUSION ON CANCER SPECIFIC AND OVERALL MORTALITY AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: RESULTS FROM A SINGLE INSTITUTION COHORT
50. PD15-12 HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.